Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence

Chronic airway infection with Pseudomonas aeruginosa is a major cause of increased morbidity and mortality in patients with cystic fibrosis (CF). The development and widespread use of nebulized antibacterial therapies, including tobramycin inhalation solution (TIS), has led to improvements in lung f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Kamal, Debonnett, Laurie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933546/
https://www.ncbi.nlm.nih.gov/pubmed/28470103
http://dx.doi.org/10.1177/1753465817691239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933546/
https://www.ncbi.nlm.nih.gov/pubmed/28470103
http://dx.doi.org/10.1177/1753465817691239

Ejemplares similares